Live feed
·
INSIDERFilingvia Quantisnow
Silk Road Medical Inc. logo

Silk Road Medical (SILK) executive Rogers sold 6,000 shares for $253K at $42.23 under a 10b5-1 plan

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Erica J. Rogers (executive at Silk Road Medical Inc., SILK) reported that they sold 6,000 shares for $253K at $42.23, and acquired 6,000 shares at $1.60 on Mar 13, 2023. After these transactions the filing shows 269,132 shares held directly.

Reporting person
Rogers Erica J.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 13, 2023Exercise or conversion of a derivative (M)Common Stock1+6,000$1.60$9,600275,132 direct
Mar 13, 2023Open-market sale (S)Common Stock1, 2-6,000$42.23$253K269,132 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Mar 13, 2023Exercise or conversion of a derivative (M)Option (right to buy)On 6,000 Common Stock1, 4-6,000--24,654 direct

Holdings before and after

  • Option (right to buy): 30,654 to 24,654 direct

Other positions listed

  • Common Stock: 83,843 indirect, Trustees of The Surace/Rogers Family Trust

Footnotes from the filing

  1. 1. The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2022.
  2. 2. This transaction was executed in multiple trades at price ranging from $41.50 to $43.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. 3. These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
  4. 4. All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Exercise or conversion of a derivative:
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

FAQ

What did Rogers report in this SILK Form 4?

Erica J. Rogers (executive at Silk Road Medical Inc., SILK) reported that they sold 6,000 shares for $253K at $42.23, and acquired 6,000 shares at $1.60 on Mar 13, 2023. After these transactions the filing shows 269,132 shares held directly.

How many SILK shares does Rogers hold after this filing?

The filing shows 269,132 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this SILK insider sale made under a 10b5-1 plan?

The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Historical context for SILK

Earlier insider filings at SILK

Quantisnow market dataNASDAQ
Silk Road Medical Inc. logo
SILK
Silk Road Medical Inc.
Market cap
30-day
Sector
Health Care
Industry
Medical/Dental Instruments
Listed since
2019
Get push alerts for SILK

Follow SILK and get a push notification the moment its next story breaks.

Full SILK profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SILK (Silk Road Medical Inc.) and more on Quantisnow.